Expression and prognostic significance of iNOS in uveal melanoma.
Uveal melanoma (UM) is the most common primary intraocular tumor in adults. Disease metastasis occurs in half of the patients and is uniformly fatal despite systemic therapy. Inducible nitric oxide synthase (iNOS) is associated with disease progression in various malignancies including cutaneous melanoma. In this retrospective cohort, we examined the prognostic value of iNOS in UM by performing immunohistochemistry on paraffin-embedded sections of primary tumors (90 patients) and matched primary and metastatic hepatic tumors (19 patients) with complete histopathological and clinical data. We show that iNOS is expressed in UM (57% of the patients) and high iNOS levels significantly (p = 0.04; hazard ratio (HR) = 2.3) predict disease-specific survival (DSS) as assessed by Kaplan-Meier analysis and univariate Cox's proportional hazards regression model. Furthermore, high iNOS expression in the UM primary tissue was significantly associated with metastatic disease and vice versa. Expression of iNOS in hepatic metastases significantly (p = 0.02) predicted a shortened survival as assessed by Kaplan-Meier analysis. However, iNOS did not appear to be a significant (p = 0.16; HR = 1.9) factor in the multivariate Cox's regression analysis performed together with the clinical parameters tumor diameter, tumor cell type, and tumor location in which only tumor diameter predicted DSS. In conclusion, iNOS predicts DSS in UM and may play a role in disease progression but it is not an independent prognostic factor.
Department of Oncology and Pathology, Cancer Center Karolinska, Karolinska Institutet, Stockholm, Sweden. Carl.Christian.Johansson@ki.se
C Christian
CC
Johansson
Dimitrios
D
Mougiakakos
Eric
E
Trocme
Charlotta
C
All-Ericsson
Mario A
MA
Economou
Olle
O
Larsson
Stefan
S
Seregard
Rolf
R
Kiessling
D000368:Aged; D002830:Choroid Neoplasms / Q000201:enzymology / Q000473:pathology; D005260:Female; D006801:Humans; D008297:Male; D008545:Melanoma / Q000201:enzymology* / Q000473:pathology; D008875:Middle Aged; D009336:Necrosis; D009361:Neoplasm Invasiveness; D009362:Neoplasm Metastasis / Q000473:pathology; D052247:Nitric Oxide Synthase Type II / Q000032:analysis / Q000235:genetics*; D011237:Predictive Value of Tests; D011379:Prognosis; D012590:Sclera / Q000473:pathology; D014604:Uveal Neoplasms / Q000201:enzymology* / Q000473:pathology
D052247:Nitric Oxide Synthase Type II